Back

Refining the CHA2DS2VASc risk stratification scheme: Shall we drop the Sex Category?

2 September 2024 (13:45 - 13:57)
Organised by: Logo
Congress Presentation Part of: Registries, observational, and other studies on atrial fibrillation Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Rui Providencia

St Bartholomew's Hospital, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation
Associate Professor D. Conen (Hamilton, CA)
Slides Video
Presentation thumbnail
Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure:the PFO-AF study
Doctor M. Badoz (Besancon, FR)
Slides Video
Presentation thumbnail
A comparison of vascular brain lesions on magnetic resonance imaging in patients with atrial fibrillation and patients with atherosclerosis
Doctor T. Stegmann (Leipzig, DE)
Slides Video
Presentation thumbnail
Phenotypes of pharmacological treatment in patients with atrial fibrillation: a latent class analysis from the prospective GLORIA-AF Registry Phase III
Doctor B. Corica (Modena, IT)
Slides Video
Presentation thumbnail
Longterm 13 Year Outcome of AF Ablation in Elderly Patients - German Ablation Registry
Professor J. Brachmann (Coburg, DE)
Slides Video

Access the full session

Session thumbnail
Registries, observational, and other studies on atrial fibrillation
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 13:45 CET
You may be interested in
thumbnail
Congress Presentation
CHA2DS2-VASc vs. CHA2DS2-VA regarding their stroke risk stratifications in patients with atrial fibrillation: insights from the GLORIA-AF registry
thumbnail
Congress Presentation
Comparison of CHA2DS2-VA and CHA2DS2-VASc scores for predicting residual risk of stroke and adverse outcomes in anticoagulated patients with atrial fibrillation: a report from a European registry
thumbnail
Congress Presentation
The new CHA2DS2-VA score: is female sex still a risk factor or not?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources